Public Employees Retirement Association of Colorado Has $20.27 Million Holdings in PerkinElmer, Inc. (PKI)

Public Employees Retirement Association of Colorado reduced its stake in PerkinElmer, Inc. (NYSE:PKI) by 0.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 293,961 shares of the medical research company’s stock after selling 1,147 shares during the period. Public Employees Retirement Association of Colorado owned about 0.27% of PerkinElmer worth $20,274,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the business. Envestnet Asset Management Inc. boosted its position in shares of PerkinElmer by 28.1% during the first quarter. Envestnet Asset Management Inc. now owns 1,979 shares of the medical research company’s stock valued at $115,000 after purchasing an additional 434 shares in the last quarter. FMR LLC boosted its holdings in PerkinElmer by 46.8% in the first quarter. FMR LLC now owns 272,519 shares of the medical research company’s stock worth $15,822,000 after acquiring an additional 86,838 shares in the last quarter. Teachers Advisors LLC boosted its holdings in PerkinElmer by 6.1% in the first quarter. Teachers Advisors LLC now owns 346,680 shares of the medical research company’s stock worth $20,128,000 after acquiring an additional 19,854 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in PerkinElmer by 15.4% in the first quarter. Dimensional Fund Advisors LP now owns 891,832 shares of the medical research company’s stock worth $51,778,000 after acquiring an additional 118,995 shares in the last quarter. Finally, Morgan Stanley boosted its holdings in PerkinElmer by 10.5% in the first quarter. Morgan Stanley now owns 272,720 shares of the medical research company’s stock worth $15,834,000 after acquiring an additional 25,976 shares in the last quarter. 92.46% of the stock is currently owned by institutional investors and hedge funds.

PerkinElmer (NYSE:PKI) last released its quarterly earnings data on Thursday, August 3rd. The medical research company reported $0.67 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.67. The business had revenue of $547.00 million during the quarter, compared to analyst estimates of $554.14 million. PerkinElmer had a return on equity of 13.44% and a net margin of 16.80%. The company’s revenue was up 2.0% on a year-over-year basis. During the same quarter last year, the business posted $0.67 EPS.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Friday, January 19th will be paid a dividend of $0.07 per share. The ex-dividend date is Thursday, January 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.39%. PerkinElmer’s payout ratio is currently 8.46%.

TRADEMARK VIOLATION WARNING: This news story was published by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.com-unik.info/2017/11/03/public-employees-retirement-association-of-colorado-has-20-27-million-holdings-in-perkinelmer-inc-pki.html.

Several equities research analysts have commented on the company. Jefferies Group LLC reissued a “hold” rating and issued a $70.00 target price on shares of PerkinElmer in a report on Friday, October 20th. Robert W. Baird reaffirmed a “buy” rating and set a $72.00 price target on shares of PerkinElmer in a report on Friday, October 20th. Morgan Stanley reaffirmed an “overweight” rating and set a $77.00 price target (down from $79.00) on shares of PerkinElmer in a report on Friday, October 6th. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and set a $67.00 price target on shares of PerkinElmer in a report on Tuesday, September 26th. Finally, Citigroup Inc. reaffirmed a “buy” rating and set a $80.00 price target (up from $74.00) on shares of PerkinElmer in a report on Tuesday, September 26th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the company. PerkinElmer presently has a consensus rating of “Hold” and an average target price of $68.14.

PerkinElmer Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

What are top analysts saying about PerkinElmer Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for PerkinElmer Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit